NCT01336920 2023-09-15Carfilzomib in Treating Patients With Relapsed or Refractory T-Cell LymphomaUniversity of NebraskaPhase 1 Completed15 enrolled
NCT02142530 2018-01-25Carfilzomib Plus Belinostat in Relapsed/Refractory NHLMassachusetts General HospitalPhase 1 Completed19 enrolled